ClinicalTrials.gg
Status unknownNCT03631264kinesiotapeUpdated Aug 15, 2018

The Effect of Kinesiotaping Method on Feeding of Late Preterm Infants.

An interventional study of Kinesiotape in Preterm Infants, sponsored by Baskent University. Status unknown at 1 site in Turkey (Türkiye). Open to participants aged 34 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2018-08-15.

Sponsored by Baskent University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2018, registered Aug 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
34 Weeks to 36 Weeks
Sex
All
01

Study summary

Problems such as poor nutrition, weak sucking, lack of suck-swallow-respiration coordination, low weight gain are among the factors increasing the risk of morbidity in late preterm infants. Early support of sucking and swallowing muscles for the development of suck-swallow coordination can shorten the maturation process and provide early discharge of late preterm infants. The aim of this study is to document kinesiotape technique to support sucking and swallowing muscles for treating nutritional problems and for reducing nutrition risks and accelerating maturation. According to power of analysis of this study, 74 infants planned to assign to kinesiotaping group or control group randomly. In kinesiotaping group, infants feeding performance will be evaluated by measuring the amount of milk invested, maximum heart rate, oxygen saturation, speed of milk intake and counting the number of swallow during feeding. Kinesiotape will be applied to masseter and hyoid muscles 24 hours later after the birth of the infant. Infants will be evaluated before kinesiotape application, 3 hour later and 24 hour later after the application.

02

Conditions studied

  • Preterm Infants

Keywords

  • preterm infants
  • kinesiotape
  • swallowing
03

In context

Lead sponsor

Baskent University is the lead sponsor of 209 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
34 Weeks to 36 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants born in Baskent University Ankara Hospital, age between 34-36.6 weeks.

Exclusion criteria

Exclusion Criteria:

  • Infants with multiple kongenital anomaly, hypoxic ischemic encephalopathy, intraventricular and intracranial hemorrhage, necrotizing enterocolitis, tracheoesophageal fistula, diaphragmatic hernia, hydrocephalus, and respiratory distress.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
74 participants (estimated)

Study arms

  • Experimental
    Kinesiotape

    Kinesiotape application to masseter and hyoid muscles of late preterm infants for improving sucking and swallowing.

    Device: Kinesiotape

  • No intervention
    Control

    In this group the late preterm infants won't be applied kinesiotaping to suck and swallow muscles.

Interventions

  • DeviceKinesiotape

    Kinesiotape application to masseter and hyoid muscles of late preterm infants to improve sucking and swallowing.

    Also known as: Control

06

What researchers measure

Primary outcomes

  1. digital stethoscope

    It helps to count the number of swallows of the baby during feeding

    Time frame: 2 minutes

07

Study locations

1 of 1 sites recruiting
  • Baskent University Ankara Hospital
    Ankara, Bahçelievler, Turkey (Türkiye)
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03631264
Lead sponsor
Baskent University
Responsible party
Nilay Comuk Balci (Associate Professor, Baskent University) — Principal investigator
First posted
Aug 15, 2018
Start date
May 1, 2018
Primary completion
Oct 1, 2018 (estimated)
Completion
Oct 1, 2018 (estimated)
Last update
Aug 15, 2018

Study contacts

Nilay Comuk Balci, Pt, PhD
Contact
nlycmk@yahoo.com
+905067115879
Deniz Anuk Ince, MD
Contact
denizanuk@yahoo.com
+905327156178
Deniz Anuk Ince, MD
study director · Associate Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion